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The hexosamine biosynthetic pathway (HBP) generates metabolites for protein N- and O-glycosyl-
ation.Wang et al. andDenzel et al. report a hitherto unknown link between the HBP and stress in the
endoplasmic reticulum. These studies establish the HBP as a critical component of the cellular
machinery of protein homeostasis.The hexosamine biosynthetic pathway
(HBP) converts glucose to UDP-N-acetyl-
glucosamine (UDP-GlcNAc) for N-glyco-
sylation of proteins in the endoplasmic
reticulum (ER) and dynamic O-glycosyla-
tion of cytosolic and nuclear proteins.
The latter modification occurs on the
hydroxyl groups of serine and threonine
residues and serves regulatory functions,
whereas the former occurs on specific
asparagine residues and is important
in the folding, stability and transport of
proteins through the secretory pathway.
In this issue of Cell, Wang et al. (2014)
and Denzel et al. (2014) report a previ-
ously unknown link between the HBP
and the unfolded protein response
(UPR), a signaling network that is acti-
vated by protein folding stress in the ER
to re-establish protein homeostasis (pro-
teostasis) (Walter and Ron, 2011). Intri-
guingly, the HBP is directly activated
by the UPR transcription factor XBP1s,
which is induced upon ER stress by
splicing of XBP1 mRNA. Upregulation of
the HBP then stimulates cytoprotective
mechanisms and longevity (Wang et al.,
2014; Denzel et al., 2014).
O-glycosylation with GlcNAc is a
modification that regulates cytosolic
and nuclear protein function in a manner
similar to phosphorylation. Increased
levels of O-GlcNAc have been observed
in cardiomyocytes after ischemia-reper-
fusion (I/R) and are associated with
cardioprotection (Ngoh et al., 2011).
After ischemia, initial damage is caused
by reperfusion when sudden restoration
of blood flow causes oxidative and
nitrosative stress and Ca2+ overload.
Stress-induced O-GlcNAc modifications
promote cell survival by regulating
processes, including Ca2+ homeostasis,defense against reactive oxygen spe-
cies, and the heat shock response
(Groves et al., 2013). Interestingly, I/R
has been reported to induce the UPR
(Llorente et al., 2013); however, a causal
link between increased O-glycosylation
and the UPR was so far unknown. To
identify factors responsible for enhanced
O-GlcNAc modification during I/R in
murine models, Wang et al. (2014) inves-
tigated whether UPR activity is involved
in regulating the HBP. Intriguingly, they
found that XBP1s transcriptionally acti-
vates GFAT1, the rate-limiting enzyme
of the HBP (Figure 1). UPR activation
and increased O-GlcNAc modification
occurred concurrently under various
stress conditions besides I/R, suggest-
ing a universal stress response mecha-
nism. This notion was further supported
by the finding that expression of XBP1s
itself, in the absence of ER stress,
led to HBP activation. Moreover, XBP1s
was required and sufficient for cardio-
protection in a GFAT1-dependent
manner. Protection was also observed
when cells were supplemented with
GlcNAc, confirming HBP products as
the critical factor. Thus, key HBP en-
zymes are directly induced by the UPR
and stimulate cardioprotection during
I/R (Figure 1).
The study by Denzel et al. (2014) sheds
light on the downstream consequences
of HBP induction during ER stress. To
identify genes involved in regulating ER
proteostasis, these authors performed a
screen for mutants of C. elegans that
were resistant to tunicamycin (Tm), an in-
hibitor of enzymes involved in N-linked
glycosylation. They discovered a gain-
of-function mutant of gfat-1 (gfat-1 gof)
that caused increased HBP activity, sup-Cell 156pressed Tm toxicity and led to extended
lif span. Addition of GlcNAc to wild-type
worms or overexpression of GFAT-1 also
led to Tm resistance and lifespan exten-
sion, demonstrating that the observed
phenotype was in fact a consequence of
increased HBP activity. Importantly, this
phenotype was independent of known
longevity factors of the insulin-like
signaling pathway (DAF-2 and DAF-16),
and no increase in HBP metabolites was
observed in a set of long-lived mutants,
including daf-2. Thus, the HBP emerges
as a novel independent longevity pathway
in C. elegans.
HBP activation was protective against
disease-related aggregation-prone pro-
teins, reducing the accumulation and
aggregation of mutant neuroserpin pro-
tein SRP-2 in the ER and significantly
improving motility of C. elegans express-
ing ER-targeted Ab42 (Denzel et al.,
2014). Notably, increased HBP activity
not only improved ER proteostasis
but also reduced the toxicity of dis-
ease-related aggregating proteins in the
cytosol, indicating a mechanism of pro-
tection across different cellular com-
partments. Interestingly, the gfat-1 gof
mutation, as well as exogenous addition
of GlcNAc, led to upregulation of SEL-
1—part of the ER ubiquitin-ligase com-
plex required for the degradation of
misfolded proteins by ER-associated
degradation (ERAD)—and also increased
proteasome activity and autophagy.
Strikingly, overexpression of SEL-1 was
sufficient to extend lifespan. Thus, by
increasing ERAD capacity, as well as
proteasomal protein degradation and
autophagy, the HBP improves proteo-
stasis in both the ER and cytosol
(Figure 1)., March 13, 2014 ª2014 Elsevier Inc. 1125
Figure 1. ER Stress-Induced HBP Leads to Proteostasis Recovery
Protein folding stress in the ER activates the ER transmembrane protein IRE1 as part of the UPR. IRE1 induces the transcription factor XBP1s by splicing XBP1
mRNA. XBP1s transcriptionally activates key enzymes of the HBP, including GFAT-1, leading to enhanced HBP activity and production of UDP-GlcNAc for the
N-glycosylation and O-glycosylation of proteins. UDP-GlcNAc also stimulates proteasomal activity, induction of the ER-associated degradation (ERAD)
component SEL-1, and autophagy. Increased HBP activity enhances proteostasis and mediates protection against toxic protein misfolding and aggregation in
the ER and cytosol. UPR-mediated O-GlcNAc modification protects cells from damage caused by oxidative stress and Ca2+ overload after I/R.The protective phenotypes observed
by Denzel et al. (2014) and Wang et al.
(2014) are a direct consequence of HBP
activation by XBP1s. Interestingly, a
recent report highlights the significant
role of XBP1s for longevity in C. elegans
(Taylor and Dillin, 2013). The new findings
on HBP-mediated longevity now raise the
question whether XBP1s-induced life-
span extension is generally mediated by
the HBP. Denzel et al. (2014) report that
induction of ER stress by Tm treatment
of C. elegans also leads to GFAT1 ex-
pression, andWang et al. (2014) observed
induction of the murine GFAT1 after
treatment with the ER stress inducer
thapsigargin. Taken together, these find-
ings strongly suggest that activation
of the HBP is a critical component of the
protective mechanisms that are orches-
trated by XBP1s and lead to lifespan
extension. Interestingly, GlcNAc has pre-
viously been reported to protect cells
from the toxicity of glucose depletion by
reducing proapoptotic UPR signaling
(Palorini et al., 2013). Denzel et al. (2014)
noted that, even though the gfat-1 gof
phenotype was dependent on UPR
function, gfat-1 gof did not activate
the UPR. These findings are in line with1126 Cell 156, March 13, 2014 ª2014 ElsevieHBP-mediated alleviation of ER stress
and point toward a negative feedback
loop.
The underlying molecular mechanisms
by which an increase in HBP metabolites
leads to improved proteostasis and cyto-
protection are not yet fully understood.
Consistent with the hypothesis that an
increase in O-GlcNAc is the major pro-
tective factor after I/R, knockdown of
the key enzyme driving this modifica-
tion (OGT) in rat myocytes significantly
reduced XBP1s-mediated protection
(Wang et al., 2014). However, the specific
O-GlcNAc-dependent proteins respon-
sible for this effect remain to be identi-
fied. In contrast, Tm resistance and
longevity in gfat-1 gof C. elegans were
independent of the key enzymes that
catalyze O-GlcNAc modification, pointing
toward increased N-glycosylation as the
main protective factor (Denzel et al.,
2014). Thus, it is conceivable that both
N- and O-glycosylation contribute to
protection from cytotoxic insults with
varying importance depending on the
type of stress. In addition, some evi-
dence suggests that the HBP-related
enzyme GalE is transcriptionally acti-
vated by XBP1s (Wang et al., 2014).r Inc.Notably, GalE drives UDP-GlcNAc con-
version to UDP-GalNAc, the first mono-
saccharide added during O-glycosylation
in the Golgi. Does ER stress-induced
HBP activation also enhance O-glycosyl-
ation in the Golgi, and does this modifica-
tion contribute to the protective effects
of the HBP? ER stress-induced HBP
activity may lead to a general improve-
ment of cellular protein folding capacity
via N-glycosylation but, in addition,
may regulate specific cellular processes.
Indeed, it is somewhat surprising that
HBP activity causes induction of protein
degradation pathways when consider-
ing that enhanced glycosylation should
improve protein folding efficiency. Inter-
estingly, Denzel et al. (2014) did not
observe global changes in N-glycosyla-
tion upon HBP activation and suggest
that proteins of the ERAD and autophagy
machinery may be directly regulated
by glycosylation. Thus, activating the
clearance of misfolded proteins, rather
than improving folding efficiency, may
be the primary protective mechanism of
the HBP upon ER stress.
The UPR and the HBP play important
roles in neurodegenerative and metabolic
diseases. The new studies highlight a
physiologically significant mechanistic
link between these pathways and could
open avenues to new therapeutic ap-
proaches. In particular, the protective
effects of supplementation with HBP
metabolites may represent a promising
therapeutic strategy.
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Microbial and danger signals result in inflammasome activation and release of inflammatory
cytokines through mechanisms that remain elusive. Cai et al. and Lu et al. show that triggering of
inflammasome sensors induces prion-like polymerization of the adaptor ASC into filaments. These
structures function as platforms for inflammatory cytokine production and represent a unified
mechanism for inflammasome assembly.Inflammasomes are key signaling ma-
chines of the innate immune system that
drive the production of the highly inflam-
matory cytokine interleukin-1b (IL-1b)
via caspase-1 activation in response to
microbial and nonmicrobial danger sig-
nals (Schroder and Tschopp, 2010).
They are composed of a danger sensor,
an adaptor protein—often ASC—and
caspase-1. Prototypical inflammasome
sensors, such as NLRP3 and AIM2,
contain a pyrin domain (PYD) that can
interact with the PYD of ASC (ASCPYD),
and ASC additionally possesses a cas-
pase recruitment domain (CARD) for
procaspase-1 engagement. Although the
primary composition of the inflamma-
somes has been resolved and much
of their physiological and pathological
functions have been revealed throughgenetic studies, the biochemical and
biophysical mechanisms of inflamma-
some activation remained mysterious. In
this issue of Cell, two elegant reports
demonstrate that AIM2 or NLPR3 trig-
gering induces a prion-like polymerization
of ASC into filaments that provide plat-
forms for activating inflammatory cytokine
production (Cai et al., 2014; Lu et al.,
2014).
Prions were originally identified as the
causative agents of spongiform encepha-
lopathies in humans, but additional
studies found prions also in lower organ-
isms such as yeast (Prusiner, 1998).
These proteins are functionally defined
by their ability to induce an energetically
favored self-polymerization process in
which an initial nucleation step converts
the native protein into the polymerizedform. The Chen laboratory previously
identified the immune adaptor MAVS as
the first beneficial prion-like protein in
mammals (Hou et al., 2011). After innate
virus sensing, the RNA receptor RIG-I nu-
cleates the N-terminal CARD of MAVS,
which then undergoes prion conversion
resulting in MAVS polymerization,
NF-kB, and IRF3 activation. Now, the
same group uses a yeast system to
screen for prion-like features in additional
immune signaling proteins that contain
death domain (DD) folds, such as a PYD
or CARD (Cai et al., 2014). By replacing
the prion domain (NM) of the yeast
Sup35 prion with candidate domains,
the authors observe that the ASCPYD ex-
hibits remarkable prion-forming abilities.
Interestingly, NLRP3PYD and AIM2 induce
ASCPYD prion conversion, and both AIM2, March 13, 2014 ª2014 Elsevier Inc. 1127
